Related Experiment Video
Updated: Sep 3, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine
Areti Sofogianni1, Nikolaos Stalikas2, Christina Antza3
1First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, Greece.
Insights
Accurate cardiovascular risk prediction is crucial for managing hypertension and dyslipidemia. Country-specific risk scores are recommended for better cardiovascular risk stratification, as general scores may be inaccurate.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Effective management of hypertension and dyslipidemia is key to reducing CVD.
- Current guidelines necessitate accurate cardiovascular risk prediction for tailored treatment intensity.
Purpose of the Study:
- To review the accuracy of widely used cardiovascular risk prediction equations.
- To identify optimal risk prediction tools for cardiovascular disease prevention.
- To guide the selection of appropriate risk scores for patient stratification.
Main Methods:
- Systematic review of existing literature on cardiovascular risk prediction equations.
- Analysis of the validation and accuracy of various risk scores.
- Comparison of performance across different populations and settings.
Main Results:
- Many existing risk scores lack external validation.
- Several equations demonstrate over- or underestimation of risk in populations different from their derivation cohorts.
- Performance variability highlights challenges in universal applicability.
Conclusions:
- Cardiovascular risk prediction is essential for optimizing preventive strategies, especially in high-risk individuals without established CVD or type 2 diabetes mellitus (T2DM).
- The accuracy of current risk prediction equations is variable and often population-specific.
- Country-specific risk scores should be prioritized for accurate cardiovascular risk stratification when available.
Abstract:
Cardiovascular disease (CVD) is the leading cause of death worldwide. Management of cardiovascular risk factors, particularly hypertension and dyslipidemia, has been shown to reduce cardiovascular morbidity and mortality. However, current guidelines recommend adjusting the intensity of blood pressure- and lipid-lowering treatment according to the cardiovascular risk of the patient. Therefore, cardiovascular risk prediction is a sine qua non for optimizing cardiovascular prevention strategies, particularly in patients without established CVD or type 2 diabetes mellitus (T2DM). As a result, several cardiovascular risk prediction equations have been developed. Nevertheless, it is still unclear which is the optimal prediction risk equation. In the present review, we summarize the current knowledge regarding the accuracy of the most widely used cardiovascular risk prediction equations. Notably, most of these risk scores have not been validated in external cohorts or were shown to over- or underestimate risk in populations other than those in which they derive. Accordingly, country-specific risk scores, where available, should be preferred for cardiovascular risk stratification.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures

